Angelaligner Will Appeal Chinese Court Decision about Premolar Extraction Solution, Which Has No Impact on Customers
- Angelalign Technology Inc. plans to appeal a Chinese court's judgment ordering its subsidiaries to stop using certain systems for premolar extraction solutions in China.
- The court's preliminary decision has not yet taken effect and has not impacted Angelalign's customers or patients.
- If Angelalign's appeal fails, the ruling will be enforced in China.
- Angelalign's CEO Fox Hu stated the decision has no immediate effect on customers and expressed confidence in winning the appeal based on past similar case victories.
45 Articles
45 Articles
Bennington Banner
Angelaligner Will Appeal Chinese Court Decision about Premolar Extraction Solution, Which Has No Impact on Customers
SHANGHAI, Aug. 12, 2026 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") http://www.angelaligner.com said today that it will appeal the August 10 first-instance judgment by the Jinan Intermediate People's Court (Jinan City, China) that directed Angel's Chinese subsidiaries to stop using…
SHANGHAI, August 13, 2026 /PRNewswire/ — Angelalign Technology Inc. (6699.HK) ("Angel") ht... The post Angelalignment will appeal the Chinese court decision regarding a premolar extraction solution, which has no impact on customers appeared first on Les Affaires.
Align Technology Wins Patent Dispute Against Angelalign in China; Angelalign Plans to Appeal
A Chinese court ruled in favor of Align Technology in an intellectual property dispute, ordering Angelalign to halt sales of certain products and pay damages, though Angelalign plans to appeal, noting the decision is limited to China and has no immediate impact on customers. Align Technology Inc announced a favorable judgment from the Jinan Intermediate People’s Court in China regarding a patent infringement lawsuit against Angelalign Technology…
Coverage Details
Bias Distribution
- 79% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
